In this work we suggested that the interaction between immune spleen T cells with tumor cells at a low ratio (mimicking a weak antitumor-IR), would produce a significantly higher concentration of chemokines (such as RANTES and MIP-1α) aimed to attract macrophages at the tumor site, than that produced by tumor cells alone or mixed with NSCs. The gene discussed is CCL5; the disease is neoplasm.